Daisuke Naruge

First-in-human phase I study of JPH203, an L-type amino acid transporter 1 inhibitor, in patients with advanced solid tumors

Naohiro Okano, Daisuke Naruge, Kirio Kawai et al. · Investigational New Drugs · 2020 · 206 citations

Medicine, Oncology, Pharmacology +5

First-in-human phaseⅠstudy of JPH203 in patients with advanced solid tumors.

Naohiro Okano, Kirio Kawai, Yoshiya Yamauchi et al. · Journal of Clinical Oncology · 2018 · 39 citations

Medicine, Oncology, Pharmacology +17

An early clinical trial of Salirasib, an oral RAS inhibitor, in Japanese patients with relapsed/refractory solid tumors

Junji Furuse, Takayasu Kurata, Naohiro Okano et al. · Cancer Chemotherapy and Pharmacology · 2018 · 33 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Pathological Complete Response in Conversion Hepatectomy Induced by Lenvatinib for Advanced Hepatocellular Carcinoma

Ryota Matsuki, Kirio Kawai, Yutaka Suzuki et al. · Liver Cancer · 2020 · 22 citations · Full text

Medicine, Oncology, Surgery +13

A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors

Akiyoshi Kasuga, Kazuhiko Nakagawa, Nagashima Fumio et al. · Investigational New Drugs · 2015 · 20 citations

Medicine, Oncology, Pharmacology +6